Eventi

Eventi consigliati

ATTIVO

Updates on ESC heart failure guidelines

IN ARRIVO

Dapagliflozin: Cardiologist Practical Guide to Prescribing Dapagliflozin

ATTIVO

Practicalities of SGLT2 inhibition – pros vs cons

IN ARRIVO

Can new-onset diabetes be prevented by dapagliflozin? Insights from DAPA-HF

IN ARRIVO

Can new-onset diabetes be prevented by dapagliflozin? Insights from DAPA-HF

ATTIVO

Practicalities of SGLT2 inhibition – pros vs cons

IN ARRIVO

Dapagliflozin: Cardiologist Practical Guide to Prescribing Dapagliflozin

ATTIVO

COVID-19 and its implications in heart failure